🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Status
Completed
Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Start Date
2009-11
Trial ID
NCT01000311
Treatments Being Tested
To evaluate the persistence of antibodies against hepatitis B at 30, 42, 54...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-04-21
Trial ID
NCT00343915
Treatments Being Tested
This is a single centre, three single administrations (Days 1, 29 and 57) a...
Status
Completed
Location
SGS Aster-Cephac
Start Date
2005-05
Trial ID
NCT00354861
In this study, subjects who received primary neonatal vaccination with hepa...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-04
Trial ID
NCT00657657
Treatments Being Tested
The purpose of the present trial is to evaluate 6 vaccine formulations of r...
Status
Completed
Location
GSK Clinical Trials Call Center
Start Date
1993-11
Trial ID
NCT00697970
Treatments Being Tested
This prospective cohort study aims to provide the evidence-based clinical g...
Status
Recruiting
Location
Family Medicine, NTUH
Start Date
2021-08-01
Trial ID
NCT04970836
Treatments Being Tested
This study will evaluate the persistence of immunity to hepatitis B 10 to 1...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-06-07
Trial ID
NCT01138098
Treatments Being Tested
The main aim of this vaccine is to prevent cervical cancer in women. Howeve...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-04-05
Trial ID
NCT00309166
Treatments Being Tested
The purpose of this study is to determine the durability of seroprotection ...
Status
Completed
Location
Clinical Research Associates of Tidewater
Start Date
2010-12
Trial ID
NCT01282762
The primary purpose of this study is to determine whether HepavaxGene TF is...
Status
Completed
Location
Center for Disease Control and Prevention Jiangsu Province
Start Date
2011-05
Trial ID
NCT01349283
Treatments Being Tested